Agrylin

{
  "unii": {
    "unii": "VNS4435G39",
    "rxcui": "236612",
    "inchikey": "TVWRQCIPWUCNMI-UHFFFAOYSA-N",
    "display_name": "ANAGRELIDE HYDROCHLORIDE ANHYDROUS",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "spl_meta": {
    "cb960074-99c1-4a73-941f-f0644a7ec219": {
      "match": "brand_token",
      "title": "AGRYLIN (ANAGRELIDE HYDROCHLORIDE) CAPSULE [TAKEDA PHARMACEUTICALS AMERICA, INC.]",
      "spl_version": "43",
      "published_date": "2026-04-10"
    }
  },
  "productid": "54092-063_80829f8c-c5ee-4e37-b5af-1b0e4e4dd5bd",
  "productndc": "54092-063",
  "dosage_form": "CAPSULE",
  "orange_book": {
    "appl_no": "020333",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 0.5MG BASE",
        "product_no": "001",
        "approval_date": "Mar 14, 1997"
      },
      {
        "rs": false,
        "rld": true,
        "te_code": null,
        "strength": "EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",
        "product_no": "002",
        "approval_date": "Mar 14, 1997"
      }
    ],
    "appl_type": "N"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "ANAGRELIDE HYDROCHLORIDE ANHYDROUS",
  "shortage_reason": "Anagrelide Hydrochloride Capsule",
  "shortage_status": "current",
  "proprietary_name": "Agrylin",
  "active_ingred_unit": "mg/1",
  "application_number": "NDA020333",
  "marketing_category": "NDA",
  "nonproprietary_name": "anagrelide hydrochloride",
  "start_marketing_date": "19970314",
  "active_numerator_strength": ".5"
}